WWP
LLY icon

Waypoint Wealth Partners’s Eli Lilly LLY Stock Holding History

Waypoint Wealth Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-782
Closed -$286K – 72
2022
Q4 		$286K Buy
+782
New +$277K 0.11% 45

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Waypoint Wealth Partners's LLY Position: Q1 2023 in Review

Waypoint Wealth Partners sold out of Eli Lilly (LLY) in Q1 2023, closing a stake of 782 shares — an estimated $286K sold.

Waypoint Wealth Partners first reported a position in LLY in Q4 2022 and held it in 1 quarter. The position peaked at $286K in Q4 2022. 2,615 funds tracked by Wall St. Rank hold LLY as of Q1 2023.

  • Waypoint Wealth Partners reported no remaining Eli Lilly position as of Q1 2023 after selling out during the quarter.
  • Waypoint Wealth Partners sold 782 Eli Lilly shares in Q1 2023, an estimated $286K.
  • Waypoint Wealth Partners first reported a position in Eli Lilly in Q4 2022 and held it in 1 quarter.
  • Waypoint Wealth Partners's Eli Lilly position peaked at $286K in Q4 2022.
  • 2,615 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2023.

Based on Waypoint Wealth Partners's 13F filing for Q1 2023, filed 1 May 2023.